Artificial intelligence is already embedded across nearly every corner of healthcare, from reading medical scans to drafting clinical notes to flagging irregular heartbeats on your wrist. The FDA has authorized over 1,400 AI-enabled medical devices, with the vast majority used in radiology. But imaging is just the starting point. Here’s where AI is making the biggest practical difference right now.
Medical Imaging and Diagnostics
Radiology dominates the FDA’s list of cleared AI devices for a straightforward reason: pattern recognition in images is one of AI’s strongest capabilities. Algorithms can scan X-rays, CT scans, mammograms, and retinal photos to flag abnormalities that a human radiologist might catch on a second look, or might miss entirely during a busy shift. These tools don’t replace the radiologist. They act as a second set of eyes, highlighting areas of concern so the final call still rests with a physician.
In practice, this means faster turnaround on urgent findings. An AI system reviewing a chest CT can prioritize a scan showing signs of a pulmonary embolism, pushing it to the top of the reading queue. For conditions like diabetic eye disease, AI screening tools can evaluate retinal images at primary care clinics, catching problems before a patient ever sees a specialist.
Smartwatches That Detect Heart Conditions
Consumer wearables now carry FDA-cleared algorithms that passively monitor your heart rhythm and alert you to possible atrial fibrillation, a condition that raises stroke risk significantly but often produces no obvious symptoms. A 2025 systematic review published in JACC: Advances found that across all smartwatch brands studied, pooled sensitivity for detecting atrial fibrillation was 95% with 97% specificity.
The Apple Watch uses a light-based sensor on your wrist to track blood flow patterns, achieving 94% sensitivity and 97% specificity. Samsung smartwatches pair their sensor data with a machine learning algorithm, reaching 97% sensitivity and 96% specificity. The Withings ScanWatch, which includes a built-in ECG sensor, showed 89% sensitivity and 95% specificity. None of these replace a formal cardiac workup, but they’re catching cases that would otherwise go unnoticed until a stroke or other complication occurred.
Cancer Treatment Matched to Your Genes
One of AI’s most promising roles is helping oncologists match cancer patients to therapies based on the genetic profile of their tumor rather than a one-size-fits-all protocol. Researchers at USC developed a machine learning model that analyzed large-scale patient data to identify mutation-treatment interactions in lung cancer. The model predicts how patients with advanced lung cancer might respond to immunotherapy, helping doctors avoid months of ineffective treatment.
The same research team identified nearly 800 genetic changes that directly affected survival outcomes across cancers, along with 95 genes significantly linked to survival in breast, ovarian, skin, and gastrointestinal cancers. This kind of analysis would take human researchers years to sift through manually. AI compresses that timeline dramatically, turning raw genomic data into actionable treatment recommendations.
AI-Assisted Surgery
Robotic surgical systems have been around for two decades, but AI is adding a new layer of intelligence. At Argonne National Laboratory, scientists are building virtual training environments where machine learning algorithms and surgeons learn from each other. The AI can identify anatomical structures in real time, overlay visual cues during a procedure, and even predict where a surgical tool is heading to raise warnings before a mistake happens.
The goal isn’t autonomous surgery. It’s augmented surgery: giving the human operator better spatial awareness, faster recognition of critical structures, and a safety net for moments of reduced visibility or fatigue. These systems learn by studying expert surgeons, then transfer those skills from simulated environments to real operating rooms. The technology is still maturing, but the trajectory is toward shorter learning curves for new surgeons and more consistent outcomes for patients.
Clinical Documentation and Administrative Tasks
Physicians spend a staggering portion of their day on paperwork, typing notes, coding diagnoses, and managing inbox messages rather than talking to patients. AI scribes are changing that. These tools listen to a patient-doctor conversation in real time and generate a structured clinical note automatically.
At Guy’s and St Thomas’ NHS hospital in London, an AI-powered speech recognition system hit a 90% adoption rate in one department and saved an estimated 60 hours of clinician time per month. Across nine NHS sites in the UK, a trial of an AI documentation tool called TORTUS freed clinicians to spend nearly 25% more time with patients and reduced burnout. Similar trials are underway in Australian hospitals in Queensland and South Australia, where AI scribes integrate directly with electronic health records. New Zealand’s public health system has endorsed an AI scribe called Heidi for use in emergency departments.
The time savings are significant not just for efficiency but for care quality. A doctor who isn’t mentally focused on documentation can listen more carefully, ask better follow-up questions, and catch details they might otherwise miss while typing.
Predicting Patient Deterioration
Hospitals increasingly use AI models that continuously analyze vital signs, lab results, and nursing assessments to predict which patients are most likely to deteriorate in the next several hours. These early warning systems flag patients headed toward sepsis, cardiac arrest, or respiratory failure before obvious clinical signs appear, giving care teams a window to intervene. The algorithms learn from millions of prior patient records, recognizing subtle patterns across dozens of data points simultaneously, something no individual clinician can do in real time across an entire ward.
Bias: A Real and Documented Problem
AI in healthcare is not without serious flaws. One widely cited example involved an algorithm used across multiple U.S. health systems that was supposed to identify patients who needed extra care management. It systematically favored healthier white patients over sicker Black patients. The reason: the algorithm was trained on healthcare spending data, not actual health needs. Because Black patients historically had less access to care and therefore generated lower costs, the system interpreted lower spending as lower need.
This kind of bias isn’t a glitch. It’s baked into the training data. Algorithms that learn from historical healthcare records will reflect every disparity embedded in those records. Populations that have been underserved show up in the data as having fewer diagnoses, fewer procedures, and lower costs, and an AI model can easily misread that as being healthier. Addressing this requires careful auditing of training data, testing algorithms across demographic groups before deployment, and ongoing monitoring after they go live.
The Scale of AI’s Healthcare Footprint
The global AI in healthcare market was valued at roughly $37 billion in 2025 and is projected to reach about $51 billion in 2026. Two forces are driving that rapid growth: healthcare systems worldwide need better efficiency and accuracy, and the global shortage of healthcare workers is making automation not just appealing but necessary. AI tools are being deployed to reduce equipment downtime, lower costs, and stretch limited clinical staff further.
With over 1,400 AI-enabled devices already authorized by the FDA and new applications emerging in mental health screening, drug discovery, and chronic disease management, AI isn’t a future possibility in healthcare. It’s the current infrastructure, expanding quickly, with both remarkable capabilities and risks that require careful oversight.